To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
The private equity firm will sell off one of the Australian company's subsidiaries, reported to be its oncology and cardiology diagnostics business, which could fetch up to A$210m. CVC Asia Pacific bought I-Med's parent in an A$2.7bn deal in 2006.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Copyright PEI Media
Not for publication, email or dissemination